Endometrial hyperplasia risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Mahshid) |
||
Line 27: | Line 27: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gynecology]] | |||
[[Category:Surgery]] |
Revision as of 22:17, 26 November 2017
Endometrial hyperplasia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Endometrial hyperplasia risk factors On the Web |
American Roentgen Ray Society Images of Endometrial hyperplasia risk factors |
Risk calculators and risk factors for Endometrial hyperplasia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]
Overview
Common risk factors in the development of endometrial hyperplasia include age>35 years, white race, nulliparity, late menopause, early menarche, tamoxifen therapy, obesity, Lynch syndrome, history of diabetes, gallbladder disease, or thyroid disease, and family history of ovarian, colon, or uterine cancers.[1]
Risk Factors
- Common risk factors in the development of endometrial hyperplasia include the following:[1]
- Age (>than 35 years)
- White race
- Nulliparity
- Late menopause (age > 55)
- Early menarche
- History of diabetes mellitus, gallbladder disease, or thyroid disease
- Obesity
- Tamoxifen therapy
- Family history of ovarian, colon, or uterine cancer
- Lynch syndrome
References
- ↑ 1.0 1.1 Endometrial Hyperplasia. The American Congress of Obstetricians and Gynecologists. http://www.acog.org/Patients/FAQs/Endometrial-Hyperplasia. Accessedon March 3, 2016.